Digitization and Its Discontents: Future Shock in Predictive Oncology

Seminars in Oncology

Volumn 37, Issue 1, 2010, Pages 60-64

  Epstein, Richard J ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

ALGORITHM; ARTICLE; CLINICAL DECISION MAKING; COST EFFECTIVENESS ANALYSIS; DOCTOR PATIENT RELATION; DRUG COST; DRUG MARKETING; GENOMICS; HEALTH CARE DELIVERY; HEALTH CARE ORGANIZATION; HEALTH CARE SYSTEM; MALIGNANT NEOPLASTIC DISEASE; MEDICAL INFORMATICS; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL;

ALGORITHMS; DRUG INDUSTRY; HUMANS; INDIVIDUALIZED MEDICINE; NEOPLASMS; PHYSICIAN-PATIENT RELATIONS; TUMOR MARKERS, BIOLOGICAL;

EID: 76749156601     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2009.12.006     Document Type: Article

References (12)

1. Parmar M.K., Barthel F.M., Sydes M., et al. Speeding up the evaluation of new agents in cancer. J Natl Cancer Inst. 100 (2008) 1204-1214
2. Jorgensen J.T. Are we approaching the post-blockbuster era?. Pharmacodiagnostics and rational drug development. Expert Rev Mol Diagn. 8 (2008) 689-695
3. El-Maraghi R.H., and Eisenhauer E.A. Review of phase II trial designs used in studies of molecular targeted agents: outcomes and predictors of success in phase III. J Clin Oncol. 26 (2008) 1346-1354
4. Chau C.H., Rixe O., McLeod H., and Figg W.D. Validation of analytic methods for biomarkers used in drug development. Clin Cancer Res. 14 (2008) 5967-5976
5. Epstein R.J. Unblocking blockbusters: using boolean text-mining to optimise clinical trial design and timeline for novel anticancer drugs. Cancer Inform. 7 (2009) 231-238
6. Epstein R.J., Leung T.W., Mak J., and Cheung P.S. Utility of a web-based breast cancer predictive algorithm for adjuvant chemotherapeutic decision making in a multidisciplinary oncology center. Cancer Invest. 24 (2006) 367-373
7. Schroder F.H., Hugosson J., Roobol M.J., et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 360 (2009) 1320-1328
8. Andriole G.L., Crawford E.D., Grubb III R.L., et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 360 (2009) 1310-1319
9. Schmid E.F., and Smith D.A. R&D technology investments: misguided and expensive or a better way to discover medicines?. Drug Discov Today 11 (2006) 775-784
10. Epstein R.A. Overdose-how excessive government regulation stifles pharmaceutical innovation (2006), Yale University Press, New Haven, CT
11. Meinert C.L. NIH multicenter investigator-initiated trials: an endangered species?. Control Clin Trials 9 (1988) 97-102
12. Bell J. Resuscitating clinical research in the United Kingdom. BMJ 327 (2003) 1041-1043